Offers of hepatitis C care do not lead to treatment Academic Article uri icon


MeSH Major

  • Hepatitis C, Chronic
  • Patient Acceptance of Health Care
  • Substance Abuse, Intravenous


  • Since 2002, clinicians have been encouraged to offer chronic hepatitis C virus (HCV) treatment to patients with injection drug use histories. We conducted 69 baseline and 35 follow-up interviews between September 2002 and November 2004 with HCV patients who were treatment-na├»ve and receiving regular medical care at an HIV or methadone clinic in New York City at baseline. Of the 31 patients reinterviewed, 20 (65%) were offered treatment but only 2 (7%) were treated. Reasons for failure to be reinterviewed were loss to follow-up at the original site of care (30), death (6), and refusal to be reinterviewed (2). Whereas offers of HCV treatment may be increasing, there is a need to improve continuity of care, patient-provider communication, and patient education regarding HCV treatment options for treatment rates to improve.

publication date

  • May 2007



  • Academic Article



  • eng

PubMed Central ID

  • PMC2231831

Digital Object Identifier (DOI)

  • 10.1007/s11524-007-9180-8

PubMed ID

  • 17394085

Additional Document Info

start page

  • 455

end page

  • 8


  • 84


  • 3